Skip to content Skip to navigation


Welcome to the Justice, Equity, Diversity and Inclusion (J.E.D.I) searchable reference database

Stanford Project Respect is pleased to bring to you this reference database focused on various aspects of Justice, Equity, Diversity, and Inclusion (J.E.D.I). We have successfully launched a virtual mini-fellowship. To learn more please visit the Stanford Justice, Equity, Diversity and Inclusion (J.E.D.I) training on the Project Respect website.

Found 1534 results
Watson KS, Cohn EG, Fair A, Menon U, Szalacha LA, Carpenter SM, Wilkins CH.  2022.  Adapting a conceptual framework to engage diverse stakeholders in genomic/precision medicine research. Health ExpectationsHealth Expectations. 25:1478-1485.
Garrick O, Mesa R, Ferris A, Kim ES, Mitchell E, Brawley OW, Carpten J, Carter KD, Coney J, Winn R et al..  2022.  Advancing Inclusive Research: Establishing Collaborative Strategies to Improve Diversity in Clinical Trials. Ethnicity & DiseaseEthnicity & Disease. 32:61-68.
Suzanne M.  2022.  Amending Federal Regulations to Counteract Language Barriers in the Informed Consent Process. Voices in BioethicsVoices in Bioethics. 8
McElroy Agrace anti.  2022.  Antidote Technologies and the National Minority Health Association Collaborate to Increase Diversity in Clinical Trial Recruitment; The relationship will bolster Antidote's DE&I initiatives in patient recruitment and support NMHA's health equity mission t.
Pugh E, Stewart J, Carter L, Calamia M, Carmichael O, Newton RL.  2022.  Beliefs, Understanding, and Barriers Related to Dementia Research Participation Among Older African Americans. Alzheimer Disease & Associated DisordersAlzheimer Disease & Associated Disorders. 36:52-57.
Zanfardino S, Mazziotto V, Bodas P.  2022.  Black Americans' willingness to participate in pediatric sickle cell clinical trials: A retrospective, systematic review. Pediatric Blood & CancerPediatric Blood & Cancer. 69
Zhi Z, Yaotiao D, Jie L, Keyi Y, Hu P, Yu J.  2022.  Chinese Cancer Patients’ Attitudes Toward Psychotherapy and Their Willingness to Participate in Clinical Trials of Psychotherapy. Cancer ControlCANCER CONTROL. 29
Gross AS, Harry AC, Clifton CS, Pasqua ODella.  2022.  Clinical trial diversity: An opportunity for improved insight into the determinants of variability in drug response. British Journal of Clinical PharmacologyBritish Journal of Clinical Pharmacology. 88:2700-2717.
McFarlane SJulian, Occa A, Peng W, Awonuga O, Morgan SE.  2022.  Community-Based Participatory Research (CBPR) to Enhance Participation of Racial/Ethnic Minorities in Clinical Trials: A 10-Year Systematic Review. Health CommunicationHealth Communication. 37:1075-1092.
Boden-Albala B.  2022.  Confronting legacies of underrepresentation in clinical trials: The case for greater diversity in research. NeuronNeuron. 110:746-748.
Macdonald G.  2022.  Data key to boosting trial diversity—and its time for CROs to act, says Phesi. FierceBiotechFierceBiotech. :N.PAG-N.PAG.
Sanchez AV, Ison JM, Hemley H, Willis A, Siddiqi B, Macklin EA, Ulysse C, Reynolds M, Schwarzschild MA, Jackson JD.  2022.  Designing the Fostering Inclusivity in Research Engagement for Underrepresented Populations in Parkinson's Disease study. Contemporary Clinical TrialsContemporary Clinical Trials. 115
Green AK, Trivedi N, Hsu JJ, Yu NL, Bach PB, Chimonas S.  2022.  Despite The FDA's Five-Year Plan, Black Patients Remain Inadequately Represented In Clinical Trials For Drugs. Health AffairsHealth Affairs. 41:368-374.
Lie MLeng Sim, McParlin C, McColl E, Graham RH, Robson SC.  2022.  Emesis in pregnancy - a qualitative study on trial recruitment failure from the EMPOWER internal pilot. Pilot and Feasibility StudiesPilot and Feasibility Studies. 8
Singer R, Crooks N, Abboud S, Patil CL.  2022.  Engaging Vulnerable Populations in Community-based Participatory Research: Lessons Learned. PROGRESS IN COMMUNITY HEALTH PARTNERSHIPS-RESEARCH EDUCATION AND ACTIONPROGRESS IN COMMUNITY HEALTH PARTNERSHIPS-RESEARCH EDUCATION AND ACTION. 16:227-234.
Masters JC, Cook JA, Anderson G, Nucci G, Colzi A, Hellio M-P, Corrigan B.  2022.  Ensuring diversity in clinical trials: The role of clinical pharmacology. Contemporary Clinical TrialsContemporary Clinical Trials. 118
Isaacs T, Murdoch J, Demjén Z, Stevenson F.  2022.  Examining the language demands of informed consent documents in patient recruitment to cancer trials using tools from corpus and computational linguistics. Health (London, England : 1997)Health (London, England : 1997). 26:431-456.
Chapagain RHari, Adhikari S, Giri BRath, Ray P, Shrestha NJyoti, Prajapati B, Joshi P, Pokharel S, Tamang SMan, Gupta BPrasad et al..  2022.  Factors affecting willingness to participate in vaccine clinical trials in an underdeveloped country: perspective from Nepal. Human vaccines & immunotherapeuticsHuman vaccines & immunotherapeutics. 18:2051413.
Wei S, Le NC, Zhu JWei, Breathett K, Greene SJ, Mamas MA, Zannad F, Van Spall HGC.  2022.  Factors Associated With Racial and Ethnic Diversity Among Heart Failure Trial Participants: A Systematic Bibliometric Review. CIRCULATION-HEART FAILURECIRCULATION-HEART FAILURE. 15
Nicholas SB, Cervantes L.  2022.  Health Care Equity and Justice Scorecard To Increase Diversity in Clinical Trial Recruitment and Retention. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGYJOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY.
Le D, Ozbeki H, Salazar S, Berl M, Turner MMitchell, Price OAcosta.  2022.  Improving African American women's engagement in clinical research: A systematic review of barriers to participation in clinical trials. Journal of the National Medical AssociationJournal of the National Medical Association. 114:324-339.